Medicine and Dentistry
8 Isoprostane
8%
Acetylcholine
6%
Acetylsalicylic Acid
51%
Acute Coronary Syndrome
8%
Adult
6%
Alzheimer's Disease
15%
Analysis
17%
Antioxidant
6%
Antiplatelet Drug
9%
Antithrombotic
13%
Antithrombotic Therapy
10%
Aptitude
6%
Association
16%
Asthma
28%
Atrial Fibrillation
8%
Biliverdin
15%
Biological Marker
14%
Bleeding
9%
Brain
10%
Breathing
14%
Carbon Monoxide
10%
Cardiology
6%
Cardiovascular Disease
11%
Cardiovascular System
13%
Cells
22%
Chemotherapeutic Agent
30%
Child
9%
Chronic Obstructive Pulmonary Disease
19%
Combination Therapy
40%
Complication
7%
Consensus
5%
Corticosteroid
5%
Cystic Fibrosis
6%
Cytokine
7%
Development
13%
Diabetes
7%
Diabetes Mellitus
10%
Diagnosis
7%
Differentiation
6%
Diseases
30%
Drug
31%
Drug Therapy
10%
Electronic Nose
15%
Enalapril Maleate
6%
Essential Thrombocythaemia
13%
Excretion
6%
Exhaled Breath Condensate
25%
Family
6%
Ganglioglioma
7%
Gene
8%
Glioblastoma
9%
Heme Oxygenase
9%
Hypothalamus
7%
Impaired Glucose Tolerance
6%
In Vitro
14%
Inpatient
44%
Low Drug Dose
13%
Lung
6%
Luteal Cell
6%
Malignant Neoplasm
6%
Marker
11%
Maturity Onset Diabetes of the Young
10%
Measurement
8%
Mechanistic Target of Rapamycin
6%
Metabolic Syndrome
10%
Metabolite
11%
Metabolomics
9%
Microglia
10%
Neoplasm
8%
Nitric Oxide
16%
Obesity
14%
Oxidative Stress
15%
Oxidoreductase
10%
Patient
100%
Phenotype
14%
Platelet
43%
Pneumonia
6%
Polycythemia vera
6%
Pregnancy
6%
Protein
7%
Raltegravir
6%
Randomized Controlled Trial
6%
Receptor
11%
Relaxation
6%
Respiratory Disease
12%
Serositis
15%
Serum
7%
Severe Asthma
12%
Smoking
13%
Sputum
8%
Symptom
7%
Syndrome
8%
Therapeutic Procedure
51%
Thrombocyte Activation
11%
Thrombocyte Function
6%
Thrombosis
21%
Thromboxane
9%
Urinary System
11%
Volatile Organic Compound
5%
Woman
7%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
79%
Acute Coronary Syndrome
7%
Adenosine Diphosphate
5%
Adverse Event
9%
Agonist
8%
Alzheimer Disease
15%
Analgesic Agent
8%
Antagonist
5%
Anticoagulant Agent
20%
Antioxidant
6%
Antithrombocytic Agent
7%
Antithrombotic Therapy
12%
Arginase
7%
Asthma
24%
Atazanavir
9%
Atrial Fibrillation
6%
Bilirubin
7%
Biliverdin
15%
Bioavailability
5%
Biological Marker
8%
Biological Product
6%
Bleeding
6%
Bronchodilating Agent
7%
Calcitonin Gene Related Peptide
16%
Carbon Monoxide
6%
Chronic Obstructive Lung Disease
23%
Cisplatin
5%
Clinical Trial
8%
Complication
7%
Corticosteroid
11%
Curcumin
9%
Cyclooxygenase 1
10%
Cyclooxygenase 2
7%
Cytokine
5%
Darunavir
6%
Death
6%
Diseases
22%
Drug
64%
Enalapril Maleate
9%
Enzyme
6%
Free Radical
6%
Glioblastoma
8%
Glioma
5%
Heme Oxygenase
9%
HIV
8%
Infection
6%
Inflammation
5%
Insulin
6%
Ketorolac
7%
Malignant Neoplasm
10%
Mammalian Target of Rapamycin Inhibitor
5%
Metabolic Syndrome X
11%
Migraine
5%
Muscarinic Receptor Blocking Agent
6%
Neoplasm
8%
Neuropeptide Y
5%
Neuroprotective Agent
6%
Nitric Oxide
7%
Noradrenalin
7%
Normal Human
5%
Obesity
10%
Oxidoreductase
10%
Peptide
5%
Pharmacodynamics
10%
Pharmacokinetics
22%
Preclinical Study
7%
Prostaglandin Synthase
6%
Protein
9%
Rat
33%
Receptor
15%
Receptor Antagonist
6%
Stevens Johnson Syndrome
5%
Symptom
6%
Tapentadol
5%
Thrombocythemia
10%
Thrombosis
12%
Thromboxane
14%
Thromboxane A2
6%
Toxicity
6%
Tritium
13%
Vaccine
5%
Vasodilator Agent
7%
Ventilator Associated Pneumonia
5%
Biochemistry, Genetics and Molecular Biology
Age
8%
Anabolism
6%
Bilirubin
6%
Biliverdin Reductase
9%
Blood Level
6%
Breathing
23%
Calcitonin Gene-Related Peptide
6%
Cyclooxygenase
7%
Darunavir
6%
Development
7%
Electric Potential
10%
Ferulic Acid
5%
Heme Oxygenase
7%
Human
6%
Lipid
6%
Membrane
5%
Metabolomics
9%
Microglia
9%
Modulation
5%
Nested Gene
7%
Neuropeptide Y
5%
Normal Human
6%
Oxidative Stress
7%
Peptide
6%
Phenotype
10%
Platelet
11%
Protein
13%
Rat
11%
Regulatory Mechanism
5%
Ritonavir
6%
Sample
10%
Thrombin
5%
Thrombocyte Activation
8%
Thromboxane
7%
Time
5%